JP2004503238A5 - - Google Patents

Download PDF

Info

Publication number
JP2004503238A5
JP2004503238A5 JP2002510643A JP2002510643A JP2004503238A5 JP 2004503238 A5 JP2004503238 A5 JP 2004503238A5 JP 2002510643 A JP2002510643 A JP 2002510643A JP 2002510643 A JP2002510643 A JP 2002510643A JP 2004503238 A5 JP2004503238 A5 JP 2004503238A5
Authority
JP
Japan
Prior art keywords
gene product
cell
cancerous
differentially expressed
colon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002510643A
Other languages
English (en)
Japanese (ja)
Other versions
JP5363695B2 (ja
JP2004503238A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/019313 external-priority patent/WO2001096523A2/en
Publication of JP2004503238A publication Critical patent/JP2004503238A/ja
Publication of JP2004503238A5 publication Critical patent/JP2004503238A5/ja
Application granted granted Critical
Publication of JP5363695B2 publication Critical patent/JP5363695B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002510643A 2000-06-15 2001-06-15 結腸癌に関するポリヌクレオチド Expired - Fee Related JP5363695B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21183500P 2000-06-15 2000-06-15
US60/211,835 2000-06-15
PCT/US2001/019313 WO2001096523A2 (en) 2000-06-15 2001-06-15 Polynucleotides related to colon cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011174312A Division JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Publications (3)

Publication Number Publication Date
JP2004503238A JP2004503238A (ja) 2004-02-05
JP2004503238A5 true JP2004503238A5 (https=) 2008-07-10
JP5363695B2 JP5363695B2 (ja) 2013-12-11

Family

ID=22788525

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002510643A Expired - Fee Related JP5363695B2 (ja) 2000-06-15 2001-06-15 結腸癌に関するポリヌクレオチド
JP2011174312A Pending JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011174312A Pending JP2011254830A (ja) 2000-06-15 2011-08-09 結腸癌に関するポリヌクレオチド

Country Status (9)

Country Link
US (1) US20030008284A1 (https=)
EP (2) EP1370684B1 (https=)
JP (2) JP5363695B2 (https=)
AT (1) ATE397094T1 (https=)
AU (1) AU2001269867A1 (https=)
DE (1) DE60134275D1 (https=)
ES (2) ES2305087T3 (https=)
PT (1) PT1370684E (https=)
WO (1) WO2001096523A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035237A1 (en) 2002-08-26 2006-02-16 Markowitz Sanford D Methods and compositions for categorizing patients
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
EP1575993A4 (en) * 2002-08-26 2007-07-25 Univ Case Western Reserve METHOD FOR TREATING PATIENTS AND IDENTIFYING THERAPEUTICS
WO2004031731A2 (en) * 2002-10-02 2004-04-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for controlling proliferation of cells
EP1767633B1 (en) * 2004-06-02 2010-08-18 TSS Biotech Inc. Novel polypeptide useful for diagnosis and treatment of cancer
DE102004037860A1 (de) * 2004-08-04 2006-03-16 Friedrich-Alexander-Universität Erlangen-Nürnberg Turmormarker zur Diagnose von Karzinomen und/oder davon abstammender Metastasen
WO2009002669A2 (en) * 2007-06-21 2008-12-31 The Johns Hopkins University Small peptides specifically bind to colorectal cancers
EP2198306A1 (en) 2007-09-06 2010-06-23 Case Western Reserve University Methods for diagnosing and treating cancers
WO2009125303A2 (en) 2008-04-10 2009-10-15 Genenews Corporation Method and apparatus for determining a probability of colorectal cancer in a subject

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668777A (en) 1981-03-27 1987-05-26 University Patents, Inc. Phosphoramidite nucleoside compounds
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5124246A (en) 1987-10-15 1992-06-23 Chiron Corporation Nucleic acid multimers and amplified nucleic acid hybridization assays using same
US5206152A (en) 1988-04-08 1993-04-27 Arch Development Corporation Cloning and expression of early growth regulatory protein genes
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
WO1990007936A1 (en) 1989-01-23 1990-07-26 Chiron Corporation Recombinant therapies for infection and hyperproliferative disorders
CA2489769A1 (en) 1989-03-21 1990-10-04 Philip L. Felgner Expression of exogenous polynucleotide sequences in a vertebrate
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
AU648261B2 (en) 1989-08-18 1994-04-21 Novartis Vaccines And Diagnostics, Inc. Recombinant retroviruses delivering vector constructs to target cells
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
ZA911974B (en) 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
US5252296A (en) 1990-05-15 1993-10-12 Chiron Corporation Method and apparatus for biopolymer synthesis
US5149655A (en) 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
AU8412991A (en) 1990-07-27 1992-03-02 Chiron Corporation Large comb-type branched polynucleotides
WO1992011033A1 (en) 1990-12-20 1992-07-09 Arch Development Corporation Control of gene expression by ionizing radiation
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
JPH07503372A (ja) 1992-01-23 1995-04-13 バイカル・インコーポレイテッド 生体外遺伝子導入
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
EP0650370A4 (en) 1992-06-08 1995-11-22 Univ California METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
CA2137361A1 (en) 1992-06-10 1993-12-23 W. French Anderson Vector particles resistant to inactivation by human serum
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
EP1024198A3 (en) 1992-12-03 2002-05-29 Genzyme Corporation Pseudo-adenoviral vectors for the gene therapy of haemophiliae
PT695169E (pt) 1993-04-22 2003-04-30 Skyepharma Inc Lipossomas multivesiculares de ciclodextrina encapsulando compostos farmacologicos e metodos para a sua utilizacao
EP0705344B8 (en) 1993-06-24 2006-05-10 Advec Inc. Adenovirus vectors for gene therapy
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5500356A (en) 1993-08-10 1996-03-19 Life Technologies, Inc. Method of nucleic acid sequence selection
DK0814154T3 (da) 1993-09-15 2009-08-31 Novartis Vaccines & Diagnostic Rekombinante alfavirusvektorer
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
AU687117B2 (en) 1993-10-25 1998-02-19 Canji, Inc. Recombinant adenoviral vector and methods of use
AU686277B2 (en) 1993-11-16 1998-02-05 Pacira Pharmaceuticals, Inc. Vesicles with controlled release of actives
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
DE69535669T2 (de) 1994-05-09 2008-12-04 Oxford Biomedica (Uk) Ltd. Retrovirale vektoren mit verminderter rekombinationsrate
US5571639A (en) 1994-05-24 1996-11-05 Affymax Technologies N.V. Computer-aided engineering system for design of sequence arrays and lithographic masks
US5474397A (en) 1994-05-31 1995-12-12 Ingersoll-Rand Company Drum access mechanism
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
AU4594996A (en) 1994-11-30 1996-06-19 Chiron Viagene, Inc. Recombinant alphavirus vectors
US5783387A (en) 1995-02-06 1998-07-21 The Regents Of The University Of California Method for identifying and quantifying nucleic acid sequence aberrations
US5599695A (en) 1995-02-27 1997-02-04 Affymetrix, Inc. Printing molecular library arrays using deprotection agents solely in the vapor phase
CA2223104A1 (en) 1995-06-07 1996-12-19 Jonathan P. Duvick Pcr-based cdna subtractive cloning method
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5654173A (en) 1996-08-23 1997-08-05 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them
US5981279A (en) * 1995-11-09 1999-11-09 Allegheny University Of The Health Sciences Compositions and methods to regulate calmodulin gene expression, and uses thereof for influencing cell growth and differentiation
DE69631540T2 (de) 1995-11-23 2005-01-27 Cancer Research Technology Ltd. Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs-suszeptilitaetsgens brca2 und dessen anwendungen
AU2189397A (en) 1996-02-08 1997-08-28 Affymetrix, Inc. Chip-based speciation and phenotypic characterization of microorganisms
US6458530B1 (en) 1996-04-04 2002-10-01 Affymetrix Inc. Selecting tag nucleic acids
WO1997042338A1 (en) 1996-05-06 1997-11-13 Chiron Corporation Crossless retroviral vectors
US6251433B1 (en) 1996-08-13 2001-06-26 Chiron Corporation Polycationic polymers
US6007991A (en) * 1997-03-28 1999-12-28 The Research Foundation Of Suny Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer
US6197332B1 (en) 1997-08-13 2001-03-06 Chiron Corporation Lipid-conjugated polyamide compounds and related compositions and methods thereof
AU1726199A (en) * 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
JP2002519000A (ja) * 1998-01-28 2002-07-02 カイロン コーポレイション ヒト遺伝子および遺伝子発現産物ii
AU764441B2 (en) * 1998-02-09 2003-08-21 Genset S.A. cDNAs encoding secreted proteins
DE19820190A1 (de) * 1998-04-28 1999-11-04 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Pankreas-Tumor
ATE386804T1 (de) * 1998-10-15 2008-03-15 Novartis Vaccines & Diagnostic Gene mit veränderter expression in metastatischen brust- oder dickdarm- krebszellen
ATE388226T1 (de) 1999-08-27 2008-03-15 Novartis Vaccines & Diagnostic Chimerische antisense-oligonukleotide und zelltransfektions-zusammensetzungen davon

Similar Documents

Publication Publication Date Title
Obama et al. Genome‐wide analysis of gene expression in human intrahepatic cholangiocarcinoma
KR102622307B1 (ko) 후성유전적 염색체 상호작용
JP2010535473A5 (https=)
CN111742061B (zh) 基于pde4d7表达和术前临床变量的术前风险分层
EP3303616B1 (en) Methods of prostate cancer prognosis
CN101836112A (zh) 用于在人急性白血病中诱导epha7和erk磷酸化的脱调节的方法和组合物
US20080050379A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
JP2010535014A5 (https=)
CN110062811A (zh) 基于人磷酸二酯酶4d变体7表达的风险评分
JP2005537007A5 (https=)
CN105765081A (zh) 一种用于预测对采用egfr抑制剂的治疗的响应性的方法
JP2004503238A5 (https=)
KR101346955B1 (ko) 뇌종양의 재발 가능성 및 생존 예후 예측용 조성물 및 이를 포함하는 키트
KR20170086469A (ko) Egfr 억제제를 사용한 치료에 대한 반응을 예측하는 방법
CN105102983A (zh) Ddr2突变作为黑素瘤或基底细胞癌的可靶向的特征
JP5114796B2 (ja) 食道癌の予後診断マーカー遺伝子およびその利用
US20020115057A1 (en) Process for identifying anti-cancer therapeutic agents using cancer gene sets
CN110452989B (zh) 生物标志物在胃癌检测、诊断中的应用
JP6949315B2 (ja) 肺扁平上皮癌と肺腺癌の鑑別評価方法
JP2004187620A (ja) 腎疾患の疾患マーカーおよびその利用
US20020165180A1 (en) Process for identifying anti-cancer therapeutic agents using cancer gene sets
CN107937520B (zh) 与结直肠癌相关的分子标记物、抑制剂、试剂盒和药剂
US20040115625A1 (en) Cancer gene determination and therapeutic screening using signature gene sets
JP2005525097A5 (https=)
KR20190086569A (ko) 암 진단에서 후생적 염색체 상호 작용의 적용